The mandatory templates
nIVD and IVD eSTAR v7.1, PreSTAR v3.1 — mandatory for 510(k)s since Oct 2023 and De Novos since Oct 2025, unless exempted.
Free field guide · PDF
The mandatory templates, the completeness checks, and the PMA expansion — with the submission practice you need.
Sourced from FDA and verified 2026 publications.
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Every figure in this guide traces to a named source — FDA and verified 2026 publications.
nIVD and IVD eSTAR v7.1, PreSTAR v3.1 — mandatory for 510(k)s since Oct 2023 and De Novos since Oct 2025, unless exempted.
'eSTAR Complete' kills the RTA review for completeness — smart auto-fill, integrated forms, and the portal size limits.
The Sep 18, 2026 draft guidance would make eSTAR mandatory for five PMA submission types — with a 60-day comment window.
This guide is market-access intelligence, not regulatory or legal advice. eSTAR versions, guidance, and reviewer practice change — professional review is required before business use.
Market Access Strategy Session
A Market Access Strategy Session maps your submission route — template selection, completeness readiness, and the PMA expansion.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team